MOSCOW, RUSSIA, August 12, 2011 (Press-News.org) - Revenue increased to US $ 1.035 billion, compared to US $ 663 million
in H1 2010
- Operating profit increased to US $ 288 million, compared to US $ 83 million
in H1 2010
- Adjusted EBITDA grew to US $ 337 million, compared to US $ 137 million
in H1 2010
- Net profit amounted to US $ 244 million, compared to net loss of US $ 13 million in H1 2010
URALCHEM Holding P.L.C. (hereinafter URALCHEM Holding or the Company), a Cypriot holding company of the URALCHEM Group (hereinafter called the Group), one of the largest producers of nitrogen and phosphate fertilisers in Russia, today announced its unaudited IFRS financial results for the 1st half of 2011 ending 30 June 2011.
Key financial figures in H1 2010-2011 ($ million)
H1 2011 H1 2010 Year-on-year change, %
Revenue 1 035,5 663,5 56,1%
Gross profit 576,7 302,6 90,6%
Gross profit margin 55,7% 45,6% 10,1%
Operating profit 288,0 82,5 249,1%
Operating profit margin 27,8% 12,4% 15,4%
Net profit (net loss) 244,0 (13,5) -
Net profit margin 23,6% - -
Adjusted EBITDA 336,8 136,9 146,0%
Adjusted EBITDA margin 32,5% 20,6% 11,9%
Cash generated from operating activities 193,5 45,1 329,0%
Dmitry Konyaev, CEO of URALCHEM, OJSC (part of the URALCHEM Group), commented on the results for the 1st Half of 2011: "In the first six months of 2011 the Company significantly increased its revenues, net income and adjusted EBITDA. The net debt / EBITDA ratio comprises 1.8. Both market conditions and the results for the reporting period suggest that 2011 will be a very successful year for the URALCHEM Group."
Financial Results
Revenue in H1 2011 grew to US $ 1035 million, compared to US $ 663 million in H1 2010. Operating profit amounted to US $ 288 million, or 28% of the revenue, compared with operating profit of US $ 83 million, or 12% of the revenue in H1 2010.
In H1 2011 net profit amounted to US $ 244 million, compared with net loss of US $ 13 million in H1 2010.
In H1 2011 adjusted EBITDA reached 337 million US $ compared to US $ 137 million for the same period last year, the increase by 146%. Adjusted EBITDA margin in H1 2011 comprised 33% of revenue, compared with 21% of revenue in H1 2010.
Markets
During H1 2011 revenues from export sales increased by 65%, reaching US $ 747 million compared to the volume of export sales of US $ 452 million in H1 2010. Export sales comprised more than 70% of total sales in monetary terms. During H1 2011 revenues from sales to the domestic market amounted to US $ 247 million, compared with US $ 179 million in H1 2010.
The dynamics of the urea market in H1 2011 were significantly different from the corresponding period in 2010: the traditional market weakening in the first quarter gave way to sharp price increases that lasted throughout the second quarter and amounted to almost $ 200 / t. The main reason for the sharp rise in prices was the imbalance between strong demand from the markets in Asia, Latin America, Africa and limited supply.
The market of ammonium nitrate largely repeated the market dynamics of urea. In the first quarter minor price fluctuations were related to low volumes of trade, due to lack of available supplies, primarily in the CIS markets. In April there was a noticeable, in comparison with the first quarter, decrease of prices due to seasonal drop in demand. From May, due to increased demand in Latin America and Turkey, prices started rising again, supported by the rapid rise in urea prices.
Since the beginning of 2011 the global market of phosphorus fertilisers demonstrated stable shortage, related to decrease in supply from major sources - the U.S., China, North Africa. As a result, throughout the first half of the year there was a steady rise in prices for phosphate fertilizers, the prices in June 2011 exceed the prices in the same period last year by more than 40%.
Supported by high prices for nitrogen, phosphate and potash fertilizers, the prices for NPK fertilisers grew throughout the first half of the year.
Sales
During the first six months of 2011, sales of commercial products of the Group increased by 8.5% compared to the same period in 2010 and totaled 2.6 million tons. The considerable growth in sales was due mainly to high demand for fertilisers both in Russia and abroad. The sales volume of phosphate fertilisers increased by 29.2%, and NPK fertilisers by 24.7% in H1 2011. Sales of ammonia decreased by 8.4% due to the increase of the share of dry products.
Sales of commercial products URALCHEM in H1 2010-2011 (thousands of tons)
Name of product H1 2011 H1 2010 Year-on year change
Ammonium nitrate and its derivatives 1 309 1 253 4,4%
NPK fertilisers 319 256 24,7%
Phosphate fertilisers 289 224 29,2%
Urea 275 265 3,7%
Ammonia 219 239 -8,4%
Other chemicals, including porous and waterproof ammonium nitrate 198 168 18,3%
Total 2 609 2 405 8,5%
Financial situation
Cash generated from operations (before tax and interest) in H1 2011 amounted to US $ 194 million compared to US $ 45 million in H1 2010. This largely resulted from increased revenue, which occurred as a result of significant growth in demand and prices in the fertiliser market.
On June 30, 2011 the Company's net debt amounted to US $ 1233.7 million. The weighted average interest rate in the loan portfolio during the six months of 2011 comprised 8.0% per annum compared to 9.6% in the same period last year.
By the end of the year 2011 the Company plans to reduce the net debt to US $ 1 150.0 million.
URALCHEM HOLDING P.L.C. is a holding company of the URALCHEM Group, which includes three fertilizer manufacturing facilities in Russia. URALCHEM is one of the largest producers of nitrogen and phosphate fertilisers in Russia and the CIS with production capacities of over 2.5 million tonnes of ammonium nitrate, 2.2 million tonnes of ammonia, 0.8 million tonnes of MAP and DAP, 0.8 million tonnes of complex fertilisers and 0.5 million tonnes of urea. URALCHEM is the second largest ammonium nitrate producer in the world and number one in Russia. URALCHEM's key production assets include Azot Branch of URALCHEM, OJSC in Berezniki, Perm Region; MFP Kirovo-Chepetsk Chemical Works, OJSC Branch in Kirovo-Chepetsk, Kirov region; Voskresensk Mineral Fertilisers, OJSC in Voskresensk, Moscow region.
Website: http://www.uralchem.ru
URALCHEM HOLDING P.L.C. Reports The First Half Of Year 2011 Unaudited IFRS Financial Results
URALCHEM Holding P.L.C., one of the largest producers of nitrogen and phosphate fertilisers in Russia, today announced its unaudited IFRS financial results for the 1st half of 2011 ending 30 June 2011
2011-08-12
ELSE PRESS RELEASES FROM THIS DATE:
Smart skin: Electronics that stick and stretch like a temporary tattoo
2011-08-12
VIDEO:
A new form of electronics, small enough to fit under a temporary tattoo, changes the way scientists think about gathering data from the human body.
Click here for more information.
CHAMPAIGN, Ill. — Engineers have developed a device platform that combines electronic components for sensing, medical diagnostics, communications and human-machine interfaces, all on an ultrathin skin-like patch that mounts directly onto the skin with the ease, flexibility and comfort of ...
Natural History Museum of Los Angeles County makes scientific history with 'pregnant plesiosaur'
2011-08-12
August 7, 2011 – A paper to be published on August 12, 2011 in the authoritative magazine Science reveals that Dr. F. Robin O'Keefe of Marshall University in Huntington, W.Va. and Dr. Luis Chiappe, Director of the Natural History Museum's Dinosaur Institute, have determined that a unique specimen now displayed in NHM's Dinosaur Hall is the fossil of an embryonic marine reptile contained within the fossil of its mother.
The 78-million-year-old, 15.4-foot-long adult specimen is a Polycotylus latippinus, one of the giant, carnivorous, four-flippered reptiles known as plesiosaurs ...
NIH-led team maps route for eliciting HIV-neutralizing antibodies
2011-08-12
Researchers have traced in detail how certain powerful HIV neutralizing antibodies evolve, a finding that generates vital clues to guide the design of a preventive HIV vaccine, according to a study appearing in Science Express this week. The discoveries were made by a team led by the Vaccine Research Center (VRC) at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.
"This elegant research brings us another step closer to an HIV vaccine and establishes a potent new technique for evaluating the human immune response ...
Supernovae parents found
2011-08-12
Pasadena, CA— Type Ia supernovae are violent stellar explosions whose brightness is used to determine distances in the universe. Observing these objects to billions of light years away has led to the discovery that the universe is expanding at an accelerating rate, the foundation for the notion of dark energy. Although all Type Ia supernovae appear to be very similar, astronomers do not know for certain how the explosions take place and whether they all share the same origin. Now, a team of researchers has examined new and detailed observations of 41 of these objects and ...
Depression linked to increased risk of stroke in women
2011-08-12
Depressed women may face an increased risk of stroke, according to new research reported in Stroke: Journal of the American Heart Association.
In six years of follow-up of women in the Nurses' Health Study, researchers found that a history of depression was associated with a 29 percent increased risk of total stroke – even after considering other stroke risk factors. Women who used anti-depressant medication — particularly selective serotonin reuptake inhibitors— had a 39 percent increased risk of stroke. Examples of these drugs are Prozac, Zoloft, and Celexa.
Anti-depressant ...
Hidden soil fungus, now revealed, is in a class all its own
2011-08-12
ANN ARBOR, Mich.---A type of fungus that's been lurking underground for millions of years, previously known to science only through its DNA, has been cultured, photographed, named and assigned a place on the tree of life.
Researchers say it represents an entirely new class of fungi: the Archaeorhizomycetes. Like the discovery of a weird type of aquatic fungus that made headlines a few months ago, this finding offers a glimpse at the rich diversity of microorganisms that share our world but remain hidden from view.
The fungal phenomenon, brought to light by researchers ...
Bilayer graphene: Another step toward graphene electronics
2011-08-12
The Nobel Prize winning scientists Professor Andre Geim and Professor Kostya Novoselov have taken a huge step forward in studying the wonder material graphene and revealing its exciting electronic properties for future electronic applications.
Writing in the journal Science, the academics, who discovered the world's thinnest material at The University of Manchester in 2004, have revealed more about the electronic properties of its slightly fatter cousin – bilayer graphene.
The researchers, from the universities of Manchester, Lancaster (UK), Nijmegen (the Netherland) ...
Engineered bacteria mop up mercury spills
2011-08-12
Thousands of tonnes of toxic mercury are released into the environment every year. Much of this collects in sediment where it is converted into toxic methyl mercury, and enters the food chain ending up in the fish we eat. New research, published in BioMed Central's open access journal BMC Biotechnology, showcases genetically engineered bacteria which are not only able to withstand high levels of mercury but are also able to mop up mercury from their surroundings.
These mercury-resistant bacteria, developed by researchers from Inter American University of Puerto Rico, ...
After-hours care affects emergency department use in Leduc
2011-08-12
(Edmonton, Canada) Access to health care and the usage of emergency departments are popular topics in the news.
David Jones, a graduate student in the University of Alberta's School of Public Health, along with Linda Carroll, professor in the School of Public Health, and Leonard Frank, executive director of the Leduc Beaumont Devon Primary Care Network, recently completed a study that examined whether or not there was a clear association between the number of visits to the emergency department and the availability of an after-hours care clinic in Leduc, Alberta.
Jones ...
Taking a 'shine' to heart repair
2011-08-12
After a heart attack or stroke, heart scarring can lead to dangerously paper-thin heart walls and a decreased ability to pump blood through the body. Although the heart is unable to completely heal itself, a new treatment developed at Tel Aviv University uses laser-treated bone marrow stem cells to help restore heart function and health.
Combining the therapeutic benefits of low-level lasers — a process called "shining" — and bone marrow stem cells, Prof. Uri Oron of the Department of Zoology at TAU's George S. Wise Faculty of Life Sciences has developed an effective, ...
LAST 30 PRESS RELEASES:
State-of-the-art fusion simulation leads three scientists to the 2024 Kaul Foundation Prize
Davos Alzheimer's Collaborative launches innovative brain health navigator program for intuitive coordination between patients and providers
Media registration now open: ATS 2025 in San Francisco
New study shows that corn-soybean crop rotation benefits are extremely sensitive to climate
From drops to data: Advancing global precipitation estimates with the LETKF algorithm
SeoulTech researchers propose a novel method to shed light on PFOS-induced neurotoxicity
Large-scale TMIST breast cancer screening trial achieves enrollment goal, paving the way for data that provides a precision approach to screeninge
Study published in NEJM Catalyst finds patients cared for by MedStar Health’s Safe Babies Safe Moms program have better outcomes in pregnancy, delivery, and postpartum
Octopus arms have segmented nervous systems to power extraordinary movements
Protein shapes can help untangle life’s ancient history
Memory systems in the brain drive food cravings that could influence body weight
Indigenous students face cumbersome barriers to attaining post-secondary education
Not all Hot Jupiters orbit solo
Study shows connection between childhood maltreatment and disease in later life
Discovery of two planets sheds new light on the formation of planetary systems
New West Health-Gallup survey finds incoming Trump administration faces high public skepticism over plans to lower healthcare costs
Reading signs: New method improves AI translation of sign language
Over 97 million US residents exposed to unregulated contaminants in their drinking water
New large-scale study suggests no link between common brain malignancy and hormone therapy
AI helps to identify subjective cognitive decline during the menopause transition
Machine learning assisted plasmonic absorbers
Healthy lifestyle changes shown to help low back pain
Waking up is not stressful, study finds
Texas A&M AgriLife Research aims for better control of widespread tomato spotted wilt virus
THE LANCET DIABETES & ENDOCRINOLOGY: Global Commission proposes major overhaul of obesity diagnosis, going beyond BMI to define when obesity is a disease.
Floating solar panels could support US energy goals
Long before the L.A. fires, America’s housing crisis displaced millions
Breaking barriers: Collaborative research studies binge eating disorders in older Hispanic women
UVA receives DURIP grant for cutting-edge ceramic research system
Gene editing extends lifespan in mouse model of prion disease
[Press-News.org] URALCHEM HOLDING P.L.C. Reports The First Half Of Year 2011 Unaudited IFRS Financial ResultsURALCHEM Holding P.L.C., one of the largest producers of nitrogen and phosphate fertilisers in Russia, today announced its unaudited IFRS financial results for the 1st half of 2011 ending 30 June 2011